The Family Firm’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-2,097
Closed -$124K 348
2024
Q2
$124K Sell
2,097
-439
-17% -$27.5K 0.03% 249
2024
Q1
$202K Buy
+2,536
New +$194K 0.05% 194
2023
Q2
Sell
-2,819
Closed -$209K 185
2023
Q1
$209K Buy
2,819
+16
+0.6% +$1.34K 0.06% 175
2022
Q4
$261K Buy
2,803
+91
+3% +$8.78K 0.08% 154
2022
Q3
$259K Buy
2,712
+12
+0.4% +$1.19K 0.08% 149
2022
Q2
$250K Buy
2,700
+88
+3% +$8.59K 0.07% 161
2022
Q1
$264K Buy
2,612
+68
+3% +$7.14K 0.07% 159
2021
Q4
$262K Buy
2,544
+11
+0.4% +$1.02K 0.07% 155
2021
Q3
$219K Buy
2,533
+11
+0.4% +$921 0.06% 172
2021
Q2
$210K Buy
+2,522
New +$207K 0.06% 172
2016
Q2
Sell
-1,938
Closed -$201K 113
2016
Q1
$201K Buy
+1,938
New +$188K 0.1% 108
2015
Q3
Sell
-1,993
Closed -$209K 105
2015
Q2
$209K Sell
1,993
-79
-4% -$8.07K 0.11% 101
2015
Q1
$214K Sell
2,072
-98
-5% -$9.92K 0.11% 104
2014
Q4
$209K Buy
+2,170
New +$191K 0.11% 100

Other funds holding CVS

The Family Firm's CVS Position: Q3 2024 in Review

The Family Firm sold out of CVS Health (CVS) in Q3 2024, closing a stake of 2,097 shares — an estimated $124K sold.

The Family Firm first reported a position in CVS in Q4 2014 and held it in 14 quarters. The position peaked at $264K in Q1 2022. 1,841 funds tracked by Wall St. Rank hold CVS as of Q3 2024.

  • The Family Firm reported no remaining CVS Health position as of Q3 2024 after selling out during the quarter.
  • The Family Firm sold 2,097 CVS Health shares in Q3 2024, an estimated $124K.
  • The Family Firm first reported a position in CVS Health in Q4 2014 and held it in 14 quarters.
  • The Family Firm's CVS Health position peaked at $264K in Q1 2022.
  • 1,841 funds tracked by Wall St. Rank held CVS Health as of Q3 2024.

Based on The Family Firm's 13F filing for Q3 2024, filed 17 Oct 2024.